CRA assisted counsel in defending against state Consumer Protection Act allegations regarding sales of consumer health product. CRA was asked to calculate unit sales dating back decades using historical sales to distributors, census of economic activity, demographic data, and other historical data sources.
CRA's RADAR Insights: Impact of US pricing strategies on orphan drug pricing in Germany - Part 3
In Part 3 of this series, RADAR data on orphan-drug pricing in Germany revealed a significant increase in manufacturer-set list prices for new orphan drugs...